Earnings Per Share, Basic in USD/shares of INTERCEPT PHARMACEUTICALS, INC. from Q2 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2013 to Q3 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Earnings Per Share, Basic for the quarter ending 30 Sep 2023 was -0.07 USD/shares, a 101% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. Earnings Per Share, Basic for the twelve months ending 30 Sep 2023 was -1 USD/shares, a 126% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2022 was 6.56 USD/shares.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2021 was -2.87 USD/shares, a 65.6% increase from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Basic for 2020 was -8.34 USD/shares, a 23.4% increase from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1 $0 -$8 -101% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $6.00 $0 +$0.11 +44% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023
Q1 2023 $6.00 -$1 $0 -32.8% 01 Jan 2023 31 Mar 2023 10-Q 27 Apr 2023
Q4 2022 $6.00 -$1 +$0.73 +59.4% 01 Oct 2022 31 Dec 2022 10-K 02 Mar 2023
Q3 2022 $6.00 $7.80 +$7.91 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$2 $0 +$0.08 +24.2% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 -$2 -$1 +$0.64 +52.5% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q4 2021 -$3 -$1 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $0 +$1.90 +94.5% 01 Jul 2021 30 Sep 2021 10-K 02 Mar 2023
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-K 02 Mar 2023
Q1 2021 -$1 01 Jan 2021 31 Mar 2021 10-K 02 Mar 2023
Q3 2020 -$2 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2015 -$2 -$4 -224% 01 Apr 2015 30 Jun 2015 10-Q 07 Aug 2015
Q4 2014 -$14 -$2 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$2 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 $1.60 +$2.39 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$13 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q2 2013 -$1 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014

INTERCEPT PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.56 +$9.43 01 Jan 2022 31 Dec 2022 10-K 02 Mar 2023
2021 -$3 +$5.47 +65.6% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$8 +$2.55 +23.4% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023
2019 -$11 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.